CRISPR In The Clinic: Regulatory Experts Discuss Development Of Cell And Gene Therapies

By Rebecca Roberts, PH.D. and Lina Jamis, M.S.

Moving through the regulatory space is often challenging for scientists trying to push their CRISPR therapies from the lab through clinical trials. Synthego not only provides GMP-grade sgRNAs; they also offer unparalleled regulatory expertise, partnering with CRISPR therapy sponsors to help them along their clinical development journey.

Synthego’s regulatory expert, Lina Jamis, provides answers to several questions including what regulatory experts do, why the clinical development of CRISPR therapy products is so time-consuming, issues with preparing regulatory documentation, and the ways Synthego can accelerate your path from bench to clinic. You will also learn more about regulatory documentation for Cell and Gene Therapy sponsors and regulatory trends and the future of CRISPR therapies.